HALO logo
halo search icon
Nuvation Bio, Inc. Class A
Nuvation Bio, Inc. Class A
NUVB · NYS

Nuvation Bio, Inc. Class A

US$4.51

Price Arrow0.27 (6.37%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownFakey Shakey - LongFakey Shakey - Long (Realtime)HALO AllHALO Consensus ValueHALO Earnings Momentum+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Nuvation Bio, Inc. Class A Overview

NUVB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NUVB

icon

Website

Nuvation Bio, Inc. Class A

icon

Telephone

icon

Address

Description

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

NUVB Price Chart

Key Stats

Market Cap

US$1.48B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.57 - 9.75

Trade Value (12mth)

US$7,287,126.00

1 week

-1.85%

1 month

-17.03%

YTD

-50.58%

1 year

108.87%

All time high

15.23

Key Fundamentals

EPS 3 yr Growth

24.60%

EBITDA Margin

-336.00%

Operating Cashflow

-$173m

Free Cash Flow Return

-35.90%

ROIC

-42.40%

Interest Coverage

-15.40

Quick Ratio

6.80

Other Data

Shares Outstanding (Fully Diluted)

378m

HALO Sector

Other Finance

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NUVB Announcements

Latest Announcements

DateAnnouncements
05 May 26
05 May 26
05 May 26
05 May 26
03 March 26

NUVB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.35-2.11-0.6locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.35-2.11-0.6locklocklock
Growth
%locklocklocklock28-510.271.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Nuvation Bio, Inc. Class A (NUVB:NYS)?
Halo FAQ
The current share price of Nuvation Bio, Inc. Class A (NUVB:NYS) is USD$4.51.
What is the 52-week high share price for Nuvation Bio, Inc. Class A (NUVB:NYS)?
Halo FAQ
The 52-week high share price for Nuvation Bio, Inc. Class A (NUVB:NYS) is USD$9.75.
What is the 52-week low share price for Nuvation Bio, Inc. Class A (NUVB:NYS)?
Halo FAQ
The 52-week low share price for Nuvation Bio, Inc. Class A (NUVB:NYS) is USD$1.57.
What is the dividend yield for Nuvation Bio, Inc. Class A (NUVB:NYS)?
Halo FAQ
Nuvation Bio, Inc. Class A (NUVB:NYS) does not pay a dividend.
What was Nuvation Bio, Inc. Class A (NUVB:NYS) last dividend payment?
Halo FAQ
Nuvation Bio, Inc. Class A (NUVB:NYS) does not pay a dividend.
What is the franking level for Nuvation Bio, Inc. Class A (NUVB:NYS)?
Halo FAQ
Nuvation Bio, Inc. Class A (NUVB:NYS) has a franking level of 0.00%.
In which sector is Nuvation Bio, Inc. Class A (NUVB:NYS) classified?
Halo FAQ
Nuvation Bio, Inc. Class A (NUVB:NYS) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.